Moonlight Therapeutics Launches First Clinical Trial of Microneedle Peanut Allergy Therapy

Moonlight begins SURVEYOR Phase I trial for peanut allergy

Moonlight Therapeutics has begun the SURVEYOR Phase I clinical trial to assess MOON101, an investigational immunotherapy for peanut allergy.The post Moonlight begins SURVEYOR Phase I trial for peanut allergy appeared first on Hospital Management.

Microneedle Stamp for Peanut Allergy Launches Clinical Trial

A microneedle stamp applied for just minutes a day is being tested as a new way to desensitize adults and... Read more » The post Microneedle Stamp for Peanut Allergy Launches Clinical Trial appeared first on Allergic Living.

Moonlight Therapeutics Launches First Clinical Trial of Microneedle Peanut Allergy Therapy

A microneedle stamp worn for just a few minutes each day to treat peanut allergies has begun clinical trials. The post Moonlight Therapeutics Launches First Clinical Trial of Microneedle Peanut Allergy Therapy appeared first on SnackSafely.com.